Joint Formulary & PAD

Formoterol (Oxis Turbohaler) - Asthma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Inhaler (dry powder)
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Formoterol (Oxis Turbohaler)
Indication :
Asthma
Group Name :
LABA
Keywords :
LABA, respiratory, asthmatics, Selective beta2-agonists, long-acting beta agonists
Brand Names Include :
Pulmicort Turbohaler
Important Information :

LABA monotherapy no longer recommended for asthma or COPD.

Not for initiation in new patients.

 

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Formoterol (Oxis Turbohaler) is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Asthma.

Committee Recommendations (0)

  • No records returned.